S, A., M, E., M, A., G, H., D, S., V, K., & N, M. (2014). The role of 99mTc-labelled glucosamine (99mTc-ECDG) in the evaluation of rheumatic joint disease: A screening experience. Nuclear medicine communications, 35(6), 655. https://doi.org/10.1097/MNM.0000000000000096
Chicago Style (17th ed.) CitationS, Angelides, El-Mashaleh M, Anagnostou M, Howe G, Spencer D, Kumar V, and Manolios N. "The Role of 99mTc-labelled Glucosamine (99mTc-ECDG) in the Evaluation of Rheumatic Joint Disease: A Screening Experience." Nuclear Medicine Communications 35, no. 6 (2014): 655. https://doi.org/10.1097/MNM.0000000000000096.
MLA (9th ed.) CitationS, Angelides, et al. "The Role of 99mTc-labelled Glucosamine (99mTc-ECDG) in the Evaluation of Rheumatic Joint Disease: A Screening Experience." Nuclear Medicine Communications, vol. 35, no. 6, 2014, p. 655, https://doi.org/10.1097/MNM.0000000000000096.